LONDON, Nov. 2, 2020 /PRNewswire/ -- Clarivate Plc
(NYSE: CCC), a global leader in providing trusted information and
insights to accelerate the pace of innovation, announced today that
Michael S. Klein, a member of the
board of directors, has informed the Company of his decision to
step down from the board. Mr. Klein previously served as
Chairman of Churchill Capital Corp, a special purpose acquisition
company (SPAC), which merged with Clarivate in May 2019.
Jerre Stead, Executive Chairman
and CEO said: "On behalf of the entire company and the Board of
Directors, I am very grateful for Michael's contributions and
guidance over the past couple years. Clarivate has benefited
significantly from Michael's business and leadership expertise. We
wish him well with his future endeavors."
With Mr. Klein's departure, the Clarivate Board will consist of
12 members.
About Clarivate
Clarivate™ is a global leader in providing solutions to
accelerate the lifecycle of innovation. Our bold mission is to help
customers solve some of the world's most complex problems by
providing actionable information and insights that reduce the time
from new ideas to life-changing inventions. Covering scientific and
academic research, pharmaceutical, biotech and healthcare
intelligence and intellectual property services, we help customers
discover, protect and commercialize their inventions using our
trusted subscription and technology-based solutions coupled with
deep domain expertise. For more information, please
visit clarivate.com.
Category: Board of Director change
Source: Clarivate Plc
Logo -
https://mma.prnewswire.com/media/1159266/Clarivate_Analytics.jpg